Pfizer (PFE) Ticks Higher on Extension of Celebrex Exclusivity; Unleases Lawsuits (TEVA) (MYL)
Tweet Send to a Friend
Pfizer (NYSE: PFE) announced earlier that the United States Patent & Trademark Office has granted Pfizer a reissue patent (U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
